What are the latest clinical trials for CLL in 2026

Latest Clinical Trials for CLL in 2026

I appreciate your question about current clinical trials. However, I need to be transparent about what I can tell you based on the medical guidelines available to me.

What I Can Share From Current Guidelines

The NCCN Guidelines (Version 1.2026, updated October 2025) that I have access to mention several treatment approaches that are being studied in clinical trials, though they don't provide a comprehensive list of all active 2026 trials. Here's what the guidelines highlight:

Active Research Areas in CLL:

1. CAR T-Cell Therapy

• Lisocabtagene maraleucel (Tecartus) continues to show strong results in real-world use
• In a recent analysis of 30 patients, this therapy achieved a 76% overall response rate with manageable side effects
• The TRANSCEND CLL 004 study demonstrated this approach's effectiveness

2. Combination Therapies Being Studied:

• BTK inhibitors + Immune checkpoint inhibitors (like nivolumab + ibrutinib)
• Venetoclax-based combinations with targeted agents
• These combinations are being evaluated for both newly diagnosed and treatment-resistant CLL

3. Richter Transformation Research

• Multiple trials are testing new approaches for when CLL transforms to aggressive lymphoma, including:
  • Pirtobrutinib (a newer BTK inhibitor)
  • CAR T-cell therapy
  • Combination checkpoint inhibitor strategies

How to Find Current 2026 Trials

Since clinical trial information changes frequently and new trials open regularly, I recommend:

✅ ClinicalTrials.gov - Search "chronic lymphocytic leukemia" and filter by:

• Status: Recruiting or Active
• Location: Your area
• Phase: I, II, or III

✅ Your Oncology Team - They have real-time access to:

• Trials at your treatment center
• Trials you may be eligible for based on your specific CLL characteristics
• Enrollment requirements and benefits

✅ Leukemia & Lymphoma Society - Maintains updated trial information and can connect you with resources

Questions to Ask Your Doctor About Trials

1. "Are there any clinical trials at this center that might be appropriate for my CLL?"
2. "Based on my specific CLL characteristics (mutations, stage, prior treatments), which trial approaches would be most relevant?"
3. "What are the potential benefits and risks of participating in a trial versus standard treatment?"
4. "How would a trial affect my current treatment plan?"

According to the NCCN Guidelines, enrollment in a clinical trial is often the preferred initial treatment option, particularly for complex cases or when standard approaches haven't worked.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.